Crown Bioscience Expands Singapore Facility with Advanced Oncology Models and Imaging Capabilities

Contributed by: Business Wire

Logo

Tags

FDA

Commercial Building & Real Estate

Construction & Property

Data Management

Technology

Pharmaceutical

Oncology

Clinical Trials

Other Technology

Biotechnology

Science

Alternative Medicine

Other Science

Data Analytics

Research

Health

oncology

More Like This

Crown Bioscience Announces New Preclinical and Translational Oncology Data Across Ten Poster Presentations at AACR 2024

Crown Bioscience's Global Oncology Research Facilities Achieve Prestigious ISO and CAP Accreditations

Crown Bioscience Partners with CTI to Support Consulting Services in Oncology Drug Development

Crown Bioscience Achieves CAP 15189 Accreditation; ISO 15189 Standard for Quality Medical Laboratory Services

Crown Bioscience Introduces OrganoidXplore: Revolutionizing Cancer Research with Rapid Large-scale Organoid Drug Screening

Biognosys Expands US Footprint with New Proteomics CRO Facility in Massachusetts

PR Newswire associated0

Crown Aesthetics Announces Launch Expansion of BIOJUVE™ Living Skin Biome Care into the United Kingdom, Ireland, and Germany

BeiGene's flagship biologics manufacturing facility and clinical R&D center at the Princeton West Innovation Campus in Hopewell, N.J., is seen. (Photo: Business Wire)

BeiGene Opens Flagship U.S. Biologics Manufacturing and Clinical R&D Facility, Continues Global Expansion to Deliver Medicines to More Patients Around the World